Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Yiboyuan Pharmaceutical Technology is a specialized contract research and manufacturing organization (CRMO) based in Wuhan, China. Founded in 2011, the company focuses on the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and fine chemicals. Operating out of the Optics Valley of China, it provides custom synthesis and process chemistry services to global pharmaceutical and biotechnology firms. Their technical expertise includes complex organic synthesis, chiral chemistry, and heterocyclic compounds. The company serves as a key supplier of high-quality chemical building blocks that support the drug discovery and development pipelines of its partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Yiboyuan Pharmaceutical Technology.